CME GROUP INC.(CME)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #257 of 2,961 stocksTOP 10%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
CME Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for CME GROUP INC. (CME), a Financials sector company. 13F Pro's AI-powered ranking engine scores CME at 69.5/100 on a 32-signal composite quality model, placing it at rank #257 of 2,961 stocks — the top 10% of the AI-ranked universe. CME scores in the top quartile across profitability (98.6), free cash flow (97.4), revenue scale (82.3). Shareholder dilution risk is elevated at 47.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), CME GROUP INC. reports quarterly revenue of $1.7B, net income of $1.0B, an operating margin of 64.9%. Top institutional holders of CME by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. CME trades on the Nasdaq exchange and files with the SEC under CIK 1156375. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CME daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CME GROUP INC. directly from SEC EDGAR. CME GROUP INC.'s 13F Pro composite quality score has ranged between 59 and 78 since 2021, currently 69.5 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.
What's Driving CME's Business? Latest 10-Q Breakdown
✓ 32/32 datapoints verifiedAI-extracted from CME GROUP INC.'s 10-Q filed 2026-07-24 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Total revenue rose 1% to $1,706.2M as a 3% decline in clearing and transaction fees to $1,352.5M was offset by 20% growth in market data revenue to $238.1M.
Biggest Revenue Drivers
Total contract volume fell 1% to 1,850.2 million and average rate per contract declined 2% to $0.678
Higher usage of certain products, increased demand by new customer segments, and price increases
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q2 2026
$1.7B
Net Income
Q2 2026
$1.0B
Free Cash Flow
Q2 2026
$923.5M
Operating Margin
Q2 2026
64.9%
ROIC
Q2 2026
16.7%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+6.4% YoYNet Income
+15.5% YoYOperating Income
+7.6% YoYEPS (Diluted)
+15.4% YoYTotal Assets
+44.4% YoYTotal Debt
-100.0% YoYOp. Cash Flow
+15.9% YoYFree Cash Flow
+16.6% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $6.52B +6.4% | $6.13B +9.9% | $5.58B +11.1% | $5.02B +7.0% | $4.69B -4.0% | $4.88B |
| Net Income | $4.07B +15.5% | $3.53B +9.3% | $3.23B +19.9% | $2.69B +2.0% | $2.64B +25.2% | $2.11B |
| Operating Income | $4.23B +7.6% | $3.93B +14.4% | $3.44B +13.9% | $3.02B +14.0% | $2.65B +0.3% | $2.64B |
| EPS (Diluted) | $11.16 +15.4% | $9.67 +9.1% | $8.86 +19.7% | $7.40 +1.5% | $7.29 +24.2% | $5.87 |
| Total Assets | $198.42B +44.4% | $137.45B +6.0% | $129.71B -25.5% | $174.18B -11.5% | $196.78B +57.9% | $124.66B |
| Total Debt | $0.00 -100.0% | $749.8M | $0.00 -100.0% | $16.0M -97.9% | $749.4M | $0.00 |
| Operating Cash Flow | $4.28B +15.9% | $3.69B +6.9% | $3.45B +13.0% | $3.06B +27.2% | $2.40B -11.5% | $2.72B |
| Free Cash Flow | $4.19B +16.6% | $3.60B +6.5% | $3.38B +13.9% | $2.97B +30.4% | $2.28B -9.6% | $2.52B |
Get alerted when CME's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for CME GROUP INC. including:
Top Institutional Holders of CME
BlackRock, Inc.
$6.7B30,566,342 shVANGUARD CAPITAL MANAGEMENT LLC
$5.2B23,661,856 shSTATE STREET CORP
$3.6B16,346,170 shMORGAN STANLEY
$2.1B9,728,195 shGEODE CAPITAL MANAGEMENT, LLC
$2.0B9,271,309 shVANGUARD PORTFOLIO MANAGEMENT LLC
$2.0B9,167,524 shCapital World Investors
$1.5B6,822,315 shJPMORGAN CHASE & CO
$1.3B5,767,731 shSanders Capital, LLC
$1.1B5,067,740 shNORGES BANK
$1.1B4,820,646 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $6.7B | 30,566,342 |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.2B | 23,661,856 |
| STATE STREET CORP | $3.6B | 16,346,170 |
| MORGAN STANLEY | $2.1B | 9,728,195 |
| GEODE CAPITAL MANAGEMENT, LLC | $2.0B | 9,271,309 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.0B | 9,167,524 |
| Capital World Investors | $1.5B | 6,822,315 |
| JPMORGAN CHASE & CO | $1.3B | 5,767,731 |
| Sanders Capital, LLC | $1.1B | 5,067,740 |
| NORGES BANK | $1.1B | 4,820,646 |
Companies Similar to CME
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Intercontinental Exchange, Inc.
AMERICAN EXPRESS CO
US BANCORP \DE\
S&P Global Inc.
TRUIST FINANCIAL CORP
AMERIPRISE FINANCIAL INC
SCHWAB CHARLES CORP
MARSH & MCLENNAN COMPANIES, INC.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Financials Companies
View all Financials →Put CME on your watchlist
Track score changes the day CME GROUP INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CME a good stock to buy?
13F Pro's AI-powered analysis of CME GROUP INC. (CME) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CME are available on the CME stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CME is classified as a large company.
Which hedge funds own CME?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CME. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CME GROUP INC.'s investment landscape.